Stay updated on Safety, PK, and PD of FDL169 in CF - Clinical Trial
Sign up to get notified when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.

Latest updates to the Safety, PK, and PD of FDL169 in CF - Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor version change and does not affect the study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedMinor page edits: correction of Queensland location entries and the addition/removal of a Locations header, removal of the HHS Vulnerability Disclosure footer link, and an updated revision tag to v3.3.3.SummaryDifference0.3%

- Check52 days agoChange DetectedThe page now displays Revision: v3.3.2 (previously v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedA note was added that PubMed publications are automatically filled from PubMed and may not be about the study, and the revision is v3.3.1, while the prior PubMed note and older revision label v3.2.0 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe notice about government funding lapse and NIH operating status was removed from the page.SummaryDifference0.4%

- Check81 days agoChange DetectedThe screenshots show only minor cosmetic/layout differences with no changes to core information such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety, PK, and PD of FDL169 in CF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.